Metabolic Control and Adaptation Mechanisms in Cancer Cells

Cancer cells exhibit profound alterations in core metabolic pathways to support uncontrolled proliferation, survival under stress and metastasis. A hallmark of these adaptations is the preference for aerobic glycolysis, often termed the Warburg effect, which enables rapid ATP generation and provision of biosynthetic precursors despite sufficient oxygen. In parallel, mitochondrial functions are remodelled: oxidative phosphorylation is modulated rather than simply suppressed, allowing dynamic shifts between glycolytic and respiratory programmes in response to environmental cues. Lipid metabolism is reprogrammed to supply membrane components and signalling lipids, while glutaminolysis and other non-glucose pathways furnish tricarboxylic acid cycle intermediates and redox cofactors. Hypoxia-inducible factors serve as master regulators under low-oxygen conditions, orchestrating gene expression programmes that enhance nutrient uptake, angiogenesis and redox homeostasis. The tumour microenvironment further shapes metabolic wiring through nutrient competition, paracrine signalling and immune-metabolic cross-talk, leading to metabolic immune suppression that favours tumour escape. Together, these mechanisms confer remarkable plasticity, enabling cancer cells to adapt to fluctuating oxygen and nutrient availability. Understanding the interplay between metabolic nodes, signal transduction and the microenvironment has revealed potential vulnerabilities: inhibitors of key enzymes within glycolysis, glutaminolysis or lipid synthesis, and modulators of redox balance, are advancing towards clinical evaluation. This integrated view underscores the global significance of metabolic control in oncogenesis and highlights opportunities for therapeutic targeting that exploit the unique metabolic dependencies of cancer cells.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Metabolic Control and Adaptation Mechanisms in Cancer Cells publication trend

The graph below shows the total number of articles in metabolic control and adaptation mechanisms in cancer cells across all publications each year (not limited to Nature Index journals).

Technical terms

Warburg effect: propensity of cancer cells to metabolise glucose to lactate under aerobic conditions, facilitating biosynthesis and rapid ATP production.

Tricarboxylic acid cycle (TCA cycle): mitochondrial series of reactions oxidising acetyl-CoA to generate NADH, FADH₂ and biosynthetic intermediates.

Glycerol-3-phosphate shuttle: mechanism transferring electrons from cytosolic NADH into mitochondria via glycerol-3-phosphate dehydrogenases, linking glucose and lipid metabolism.

Glutaminolysis: catabolic pathway converting glutamine to glutamate and α-ketoglutarate to fuel the TCA cycle and biosynthesis.

Reactive oxygen species (ROS): chemically reactive molecules containing oxygen, produced by mitochondrial activity and affecting redox signalling and damage.

Hypoxia-inducible factor (HIF): transcription factor stabilised under low oxygen that regulates genes involved in metabolism, angiogenesis and adaptation to hypoxia.

References

1. Glycerol 3-phosphate dehydrogenases (1 and 2) in cancer and other diseases. Experimental & Molecular Medicine (2024).
2. Metabolic‐Immune Suppression Mediated by the SIRT1‐CX3CL1 Axis Induces Functional Enhancement of Regulatory T Cells in Colorectal Carcinoma. Advanced Science (2025).
3. A HIF1α-GPD1 feedforward loop inhibits the progression of renal clear cell carcinoma via mitochondrial function and lipid metabolism. Journal of Experimental & Clinical Cancer Research (2021).